文献速递神经免疫

抗体介导脑炎脑脊液生物标志物的前瞻性定量研究

Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
PubMed 文献 · Neurology · 2021-04-01

该研究在45例抗体介导脑炎(AME)患者诊断时及39例认知正常对照中检测脑脊液神经元、神经轴索损伤、神经炎症和突触功能标志物,发现NfL和YKL-40升高而突触标志物降低,YKL-40/SNAP-25比值可极好区分患者与对照,且部分标志物与疾病严重程度和12个月结局相关。

要点

  • AME诊断时脑脊液NfL和YKL-40升高,总tau稳定,VILIP-1、SNAP-25和neurogranin降低。
  • YKL-40/SNAP-25对数比值区分AME与认知正常者的AUC为0.99(95%CI 0.97, >0.99)。
  • 较低VILIP-1和SNAP-25及较高YKL-40/SNAP-25与更高mRS评分相关。

核心结论

  • 脑脊液标志物提示AME急性期神经元完整性相对保留,但存在神经轴索损伤。
  • 突触功能标志物降低可能反映抗体介导的细胞表面受体内化,或为抗体介导突触功能障碍的急性相关指标。

研究设计与样本

  • 前瞻性研究,纳入45例诊断时AME患者(NMDA受体34例,LGI1/CASPR2 11例)和39例年龄性别相似的认知正常个体。
  • 在20例纵向随访患者中评估生物标志物与改良Rankin量表(mRS)评分的关联。

主要发现

  • AME患者就诊时神经轴索损伤标志物NfL和神经炎症标志物YKL-40升高。
  • 神经元损伤标志物总tau稳定,突触功能标志物VILIP-1、SNAP-25和neurogranin降低。
  • YKL-40/SNAP-25对数比值区分患者与认知正常者的AUC为0.99(95%CI 0.97, >0.99)。
  • 在纵向随访患者中,较低年龄(ρ=-0.56;p=0.01)、较低VILIP-1(ρ=-0.60;p<0.01)和SNAP-25(ρ=-0.54;p=0.01)、较高log10(YKL-40/SNAP-25)(ρ=0.48;p=0.04)与更高疾病严重程度(更高mRS评分)相关。
  • 就诊时较高YKL-40(ρ=0.60;p=0.02)和neurogranin(ρ=0.55;p=0.03)与出院后12个月更高mRS评分相关。

临床怎么用

  • 脑脊液YKL-40/SNAP-25比值或有助于区分AME与认知正常者。
  • 检测VILIP-1、SNAP-25、YKL-40和neurogranin可能帮助评估疾病严重程度和12个月结局。

局限性

  • 纵向评估mRS关联的亚组样本量较小(n=20)。
  • 研究未报告脑脊液标志物与抗体类型或具体治疗的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether neuronal and neuroaxonal injury, neuroinflammation, and synaptic dysfunction associate with clinical course and outcomes in antibody-mediated encephalitis (AME), we measured biomarkers of these processes in CSF from patients presenting with AME and cognitively normal individuals. METHODS: Biomarkers of neuronal (total tau, VILIP-1) and neuroaxonal damage (neurofilament light chain [NfL]), inflammation (YKL-40), and synaptic function (neurogranin, SNAP-25) were measured in CSF obtained from 45 patients at the time of diagnosis of NMDA receptor (n = 34) or LGI1/CASPR2 (n = 11) AME and 39 age- and sex-similar cognitively normal individuals. The association between biomarkers and modified Rankin Scale (mRS) scores were evaluated in a subset (n = 20) of longitudinally followed patients. RESULTS: Biomarkers of neuroaxonal injury (NfL) and neuroinflammation (YKL-40) were elevated in AME cases at presentation, whereas markers of neuronal injury and synaptic function were stable (total tau) or decreased (VILIP-1, SNAP-25, neurogranin). The log-transformed ratio of YKL-40/SNAP-25 optimally discriminated patients from cognitively normal individuals (area under the receiver operating characteristic curve 0.99; 95% confidence interval 0.97, >0.99). Younger age (ρ = -0.56; p = 0.01), lower VILIP-1 (ρ = -0.60; p < 0.01) and SNAP-25 (ρ = -0.54; p = 0.01), and higher log10(YKL-40/SNAP-25) (ρ = 0.48; p = 0.04) associated with greater disease severity (higher mRS score) in prospectively followed patients. Higher YKL-40 (ρ = 0.60; p = 0.02) and neurogranin (ρ = 0.55; p = 0.03) at presentation were associated with higher mRS scores 12 months following hospital discharge. CONCLUSIONS: CSF biomarkers suggest that neuronal integrity is acutely maintained in AME, despite neuroaxonal compromise. Low levels of biomarkers of synaptic function may reflect antibody-mediated internalization of cell surface receptors and may represent an acute correlate of antibody-mediated synaptic dysfunction, with the potential to inform disease severity and outcomes.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Day GS, Yarbrough MY, Körtvelyessy P, et al. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis. Neurology. 2021. PMID: 33795390. doi:10.1212/WNL.0000000000011937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。